When was Alvotech founded?

Alvotech was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Where is Alvotech located?

Alvotech is headquartered in Reykjavik, Iceland. It is registered at Ground Floor, No. 32, Salarpuria Tower-II, Chikku Lakshmaiah Layout, Luskar Hosur Road, Ko, ramangala, Bangalore, Bangalore, Karnataka, India, 560029.

How many employees does Alvotech have?

As of Aug 31, 2026, the latest employee count at Alvotech is 1168.

Is Alvotech a funded company?

Alvotech is a funded company, having raised a total of $150M across 9 funding rounds to date. The company's 1st funding round was a $50M Series B round, raised on Dec 17, 2018.

When was the latest funding round of Alvotech?

Alvotech's latest funding was a $78.2M Post IPO round on Jun 04, 2025, with participation from 0 investor.

Is Alvotech a Diversified Pharmaceuticals company?

The primary sector of Alvotech is Diversified Pharmaceuticals.

Where does Alvotech rank among its competitors?

Alvotech ranks 12th amongst 1877 active competitors, of which 96 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Alvotech?

Alvotech's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Alvotech - 2026 Company Profile, Funding & Competitors

Alvotech is a public company based in Reykjavik (Iceland), founded in 2013. It operates as a R&D company focused on manufacturing drugs for multiple therapeutic areas. Alvotech has raised $150M in funding from investors like Baxter, Shinhan Bank and Fuji Pharmaceutical. The company has 1877 active competitors, including 96 funded and 203 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.

Sectors and market segments that Alvotech operate in

Alvotech serves in the Life Sciences market segments.The primary business model of Alvotech is:

Life Sciences > Diversified Pharmaceuticals > ***** **** > ***** ******

Company Details

R&D company focused on manufacturing drugs for multiple therapeutic areas. Its purpose is to improve the health and quality of life of patients by improving access to proven treatments for various diseases.

Website: www.alvotech.com/
Social
Email ID: *****@alvotech.com
Phone Number: +354 **********
Registered Address: Ground Floor, No. 32, Salarpuria Tower-II, Chikku Lakshmaiah Layout, Luskar Hosur Road, Ko, ramangala, Bangalore, Bangalore, Karnataka, India, 560029

Key Metrics

Founded Year

2013

Location

Reykjavik, Iceland

Stage

Public

Total Funding

$150M in 9 rounds

Latest Funding Round

Post IPO, Jun 04, 2025, $78.2M

Investors

Baxter & 4 more

Ranked

12^th among 1877 active competitors

Employee Count

1,168 as on Aug 31, 2026

Investment & Acquisitions

Iverslee

Similar Companies

AbbVie & 1905 more

Exit Details

Public

View Alvotech's full profile

Alvotech is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Alvotech Hf. CIN: 0804.569.567 , Belgium, Active	Aug 01, 2023	-	-	-
ALVOTECH BIOSCIENCES INDIA PRIVATE LIMITED CIN: U24299KA2022FTC161107 , India, Active	May 11, 2022	₹10 - ₹50 Cr (As on Mar 31, 2025)	-

Alvotech got listed on Jun 16, 2022.

Click here to take a look at Alvotech's IPO in detail

Alvotech has raised a total funding of $150M over 9 rounds. Its first funding round was on Dec 17, 2018. Alvotech has 5 institutional investors.

Here is the list of recent funding rounds of Alvotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 04, 2025	$78.2M	Post IPO	-	-	-	-
Jan 19, 2023	$136M	Post IPO	-	-	-	-
Dec 16, 2022	Undisclosed	Post IPO	-	-	-	-

Access funding benchmarks and valuations. Sign up today!

View details of Alvotech's funding rounds and investors

Alvotech's employee count trend

Alvotech has 1,168 employees as of Aug 26. Here is Alvotech's employee count trend over the years:

Uncover Alvotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alvotech include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Alvotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	72/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
12th	Alvotech 2013, Reykjavik (Iceland), Public	R&D company focused on manufacturing drugs for multiple therapeutic areas	$150M	Shinhan Bank, Baxter & 3 others	68/100